Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy

Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy

Purpose: Current standard of care for patients with breast cancer with a positive node on sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy is axillary dissection with irradiation of the regional nodes, but it is unknown whether axillary lymph node dissection (ALND) can be safely omit...

Full description

Bibliographic Details
Main Authors: Diane C. Ling, MD, Nick A. Iarrobino, BS, Colin E. Champ, MD, Atilla Soran, MD, MPH, Sushil Beriwal, MD, MBA
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109419301502

Internet

http://www.sciencedirect.com/science/article/pii/S2452109419301502

Similar Items